Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1979 1
1981 1
1985 1
2007 1
2009 1
2015 1
2016 1
2017 3
2018 2
2019 3
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for B. feroldi
Your search for B. Faroldi retrieved no results
Primary progressive aphasia and motor neuron disease: A review.
Aiello EN, Feroldi S, De Luca G, Guidotti L, Arrigoni E, Appollonio I, Solca F, Carelli L, Poletti B, Verde F, Silani V, Ticozzi N. Aiello EN, et al. Front Aging Neurosci. 2022 Sep 8;14:1003792. doi: 10.3389/fnagi.2022.1003792. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36158556 Free PMC article. Review.
As to case reports/series (N = 35), which included 61 PPA-MND patients, the following findings yielded: (1) PNFA is more frequent than SD in PPA-MND; (2) in PPA-MND, the most prevalent motor phenotypes are amyotrophic lateral sclerosis and predominant-upper MND, with bulbar invol …
As to case reports/series (N = 35), which included 61 PPA-MND patients, the following findings yielded: (1) PNFA is more frequent than SD in …
Total synthesis, isolation, surfactant properties, and biological evaluation of ananatosides and related macrodilactone-containing rhamnolipids.
Cloutier M, Prévost MJ, Lavoie S, Feroldi T, Piochon M, Groleau MC, Legault J, Villaume S, Crouzet J, Dorey S, Dìaz De Rienzo MA, Déziel E, Gauthier C. Cloutier M, et al. Chem Sci. 2021 May 4;12(21):7533-7546. doi: 10.1039/d1sc01146d. Chem Sci. 2021. PMID: 34163844 Free PMC article.
Herein, we present the isolation, structural characterization, and total synthesis of ananatoside A, a 15-membered macrodilactone-containing glucolipid, and ananatoside B, its open-chain congener, from organic extracts of P. ananatis. ...Lastly, we demonstrate that ananato …
Herein, we present the isolation, structural characterization, and total synthesis of ananatoside A, a 15-membered macrodilactone-containing …
Superior mesenteric artery-related outcomes in fenestrated/branched endografting for complex aortic aneurysms.
Gallitto E, Faggioli G, Vacirca A, Lodato M, Cappiello A, Logiacco A, Feroldi F, Pini R, Gargiulo M. Gallitto E, et al. Front Cardiovasc Med. 2023 Sep 13;10:1252533. doi: 10.3389/fcvm.2023.1252533. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37771670 Free PMC article.
The SMA configuration was classified into three types according to the angle between the SMA main trunk and the aorta: (A) perpendicular, (B) downward, and (C) upward. SMA-related technical success (SMA-TS: cannulation and stenting, patency at completion angiography withou …
The SMA configuration was classified into three types according to the angle between the SMA main trunk and the aorta: (A) perpendicular, ( …
Type II endoleaks after fenestrated/branched endografting for juxtarenal and pararenal aortic aneurysms.
Gallitto E, Faggioli GL, Campana F, Feroldi FM, Cappiello A, Caputo S, Pini R, Gargiulo M. Gallitto E, et al. J Vasc Surg. 2024 Jan 26:S0741-5214(24)00257-X. doi: 10.1016/j.jvs.2024.01.197. Online ahead of print. J Vasc Surg. 2024. PMID: 38280685
However, their occurrence and natural history after fenestrated/branched endografting (F/B-EVAR) for juxtarenal and pararenal aneurysms (J/P-AAAs) have been scarcely investigated. Aim of this study was to report incidence, risk factors, and natural history of pEL2 after F/ …
However, their occurrence and natural history after fenestrated/branched endografting (F/B-EVAR) for juxtarenal and pararenal aneurys …
New Preloaded System for Renal and Visceral Arteries in Fenestrated Endografting.
Gallitto E, Faggioli G, Spath P, Feroldi FM, Pini R, Logiacco A, Sufali G, Caputo S, Gargiulo M. Gallitto E, et al. J Endovasc Ther. 2023 Jun 13:15266028231179868. doi: 10.1177/15266028231179868. Online ahead of print. J Endovasc Ther. 2023. PMID: 37309170
Survival, freedom from reinterventions (FFRs), and freedom from TTVs-instability (FFTVVs-instability) were analyzed during follow-up. RESULTS: Among 157 F/B-EVAR cases, 74 (47%) NPS-FEVAR were planned and enrolled in the study [48 (65%) J/P-AAAs; 26 (35%) TAAAs]. ...
Survival, freedom from reinterventions (FFRs), and freedom from TTVs-instability (FFTVVs-instability) were analyzed during follow-up. RESULT …
Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers.
Martinón-Torres F, Diez-Domingo J, Feroldi E, Jordanov E, B'Chir S, Da Costa X. Martinón-Torres F, et al. Pediatr Infect Dis J. 2019 Mar;38(3):317-322. doi: 10.1097/INF.0000000000002231. Pediatr Infect Dis J. 2019. PMID: 30408001 Clinical Trial.
BACKGROUND: This study assessed a pediatric mixed hexavalent diphtheria (D)-tetanus (T)-acellular pertussis (aP)-inactivated poliovirus (IPV)-hepatitis B (HB)-Haemophilus influenzae b [polyribosylribitol phosphate (PRP-T)]-pentavalent (DTaP-IPV//PRP-T)-hexavalent pr …
BACKGROUND: This study assessed a pediatric mixed hexavalent diphtheria (D)-tetanus (T)-acellular pertussis (aP)-inactivated poliovirus (IPV …
Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic.
Prymula R, Kieninger D, Feroldi E, Jordanov E, B'Chir S, DaCosta X. Prymula R, et al. Pediatr Infect Dis J. 2018 Aug;37(8):823-830. doi: 10.1097/INF.0000000000002109. Pediatr Infect Dis J. 2018. PMID: 29762363 Clinical Trial.
To support a fully liquid, diphtheria (D)-tetanus (T)-acellular pertussis (aP)-inactivated poliovirus (IPV)-hepatitis B (HB)-Haemophilus influenzae b (PRP-T) vaccine in Europe using a 2, 3, 4 month primary series and a booster at 11-15 months of age. ...
To support a fully liquid, diphtheria (D)-tetanus (T)-acellular pertussis (aP)-inactivated poliovirus (IPV)-hepatitis B (HB)-Haemophi …
A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
López P, Arguedas Mohs A, Abdelnour Vásquez A, Consuelo-Miranda M, Feroldi E, Noriega F, Jordanov E, B Chir S, Zambrano B. López P, et al. Pediatr Infect Dis J. 2017 Nov;36(11):e272-e282. doi: 10.1097/INF.0000000000001682. Pediatr Infect Dis J. 2017. PMID: 28719500 Clinical Trial.
BACKGROUND: Hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae type b (DTaP-IPV-HB-PRP-T)-containing vaccines are increasingly the standard of care. ...The anti-aP component (filamentous hemagglutinin [FHA] an …
BACKGROUND: Hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae type b …
18 results